U.S. President Donald Trump expressed confidence on Wednesday that China will soon impose the death penalty for fentanyl manufacturing and trafficking, signaling renewed optimism for a bilateral crackdown on the opioid crisis. Speaking ahead of signing the HALT Fentanyl Act, Trump emphasized collaboration with Beijing to halt the flow of synthetic opioids, which have claimed over 450,000 American lives in the past decade.
Fentanyl, a powerful synthetic opioid, remains a top cause of overdose deaths in the U.S., and Washington continues to pressure Beijing to tighten control over precursor chemicals exported from China. Trump’s remarks follow a series of recent moves aimed at reining in the deadly drug trade, including the February imposition of 20% tariffs on Chinese goods linked to fentanyl-related issues.
“I think China’s going to go from doing nothing to issuing the death penalty for those producing fentanyl and sending it here,” Trump told reporters. He added that talks with Chinese leader Xi Jinping were progressing and that Beijing was taking “big steps” in response.
In recent weeks, China has added two more fentanyl precursors—4-piperidone and 1-boc-4-piperidone—to its list of controlled substances. Authorities have also ramped up enforcement, seizing over 2 tons of drugs and arresting 262 individuals for trafficking. Over 1,300 prosecutions and 700 arrests for drug-related money laundering have been reported this year, showing a 2.1% increase from last year.
China, however, has pushed back on U.S. demands to publicize its efforts prominently and has accused Washington of politicizing the fentanyl issue. Still, Trump’s latest remarks suggest a possible breakthrough in cooperation as both nations grapple with rising overdose deaths and escalating tensions.


U.S. Soybean Shipments to China Gain Momentum as Trade Tensions Ease
Apple Alerts EU Regulators That Apple Ads and Maps Meet DMA Gatekeeper Thresholds
UN General Assembly Demands Russia Return Ukrainian Children Amid Ongoing Conflict
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Israel Receives Body of Deceased Hostage as Rafah Crossing Reopening Hinges on Final Returns
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp
U.S. Officials Say Afghan Suspect in D.C. National Guard Shooting Radicalized After Arrival
Trump Administration Tightens H-1B Visa Vetting With New Focus on Free Speech and Censorship
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative
Maduro Confirms “Respectful” Call With Trump, Signals Openness to Diplomatic Dialogue
Taiwan Signals Openness to Renew Ties with Honduras as Election Unfolds
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
USPS Expands Electric Vehicle Fleet as Nationwide Transition Accelerates
National Guard Member Killed in White House-Area Shooting Sparks Terror Probe and Immigration Review
Minneapolis Leaders Push Back as Trump Escalates Rhetoric Against Somali Community
California Launches Portal for Reporting Alleged Misconduct by Federal Immigration Agents 



